Connect with us

Artificial Intelligence

BridgeBio Pharma, Inc. Appoints Biotech Trailblazers Brent Saunders and Randy Scott and Renowned Economist Andrew Lo to Board of Directors

GlobeNewswire

Published

on

PALO ALTO, Calif., June 24, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (NASDAQ: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, today announced that it has added three new independent directors to its board: former Allergan CEO and biopharma deal-maker, Brent Saunders; genomics pioneer and entrepreneur, Randy Scott, Ph.D.; and renowned economist and BridgeBio co-founder, Andrew Lo, Ph.D.
“We are privileged to welcome these world-class company builders, innovators, and thought leaders to our board where they can help us construct and advance a vast pipeline of meaningful medicines for patients with genetic disease,” said BridgeBio CEO and founder Neil Kumar, Ph.D. “Brent has a remarkable track record of leading companies to growth across many therapeutic areas. Randy is a giant in genomic medicine who has used his entrepreneurial skills to connect genetic information to patients in profound ways. Andrew’s groundbreaking financial engineering work led to the founding of BridgeBio and inspires us to find new ways to accelerate the drug development process. I look forward to working with and learning from these leaders as we seek to discover, develop, and deliver life-changing medicines at scale. It’s day one at BridgeBio and we are ready to go.”Brent SaundersMr. Saunders will bring his considerable experience to bear as he advises BridgeBio on scaling its business across new product and therapeutic areas, expanding into new geographies, developing commercial expertise, and utilizing new corporate structures.Mr. Saunders most recently served as chairman, president and chief executive officer of Allergan. In this capacity, he led the company to launch more than 15 products and achieve 9.4% revenue growth until its merger with AbbVie in 2020. He previously served as president and CEO at Actavis, where he led a $15 billion global pharmaceutical business until its merger with Allergan. He initially joined Actavis as part of the company’s acquisition of Forest Laboratories, where he served as president and CEO. Before joining Forest Laboratories, Mr. Saunders served as president and CEO of Bausch & Lomb. Mr. Saunders received his bachelor’s degree in economics and East Asian studies from the University of Pittsburgh, a Juris Doctor degree from Temple University School of Law and his Master of Business Administration from Temple University School of Business.“I appreciate BridgeBio’s ability to accelerate the development of therapeutics for patients in need and I have been impressed with their unheard-of progress in pipeline growth in such a short time. As the company moves toward potential commercialization of its lead products, I’m eager to bring my experience leading and growing global pharmaceutical companies to help guide BridgeBio in its game-changing efforts,” said Mr. Saunders.Randy Scott, Ph.D.Dr. Scott will bring his deep expertise to BridgeBio and advise the company on how best to utilize the broad ecosystem of genomic medicine (beyond the pill) so that a wider universe of patients can be served. BridgeBio’s decentralized business model will also benefit from Dr. Scott’s guidance on developing and maintaining a strong culture of excellence.Dr. Scott pioneered the introduction of genetics into everyday medical care as the founder of multiple cutting-edge biotech companies. Dr. Scott recently served as chief executive officer and executive chairman at Invitae, a company he co-founded to bring genetic information into routine medical practice. Prior to Invitae, he founded Genomic Health and served as the company’s CEO and later executive chairman – leading the company to develop and launch genomic diagnostic tests for breast, colon, and prostate cancer. Earlier in his career, Dr. Scott served as the president and chief scientific officer for Incyte, one of the first genetic information companies. He co-founded and currently serves as chairman of Genome Medical, a telegenomics-based clinical care company. Dr. Scott earned his bachelor’s degree in chemistry from Emporia State University and his doctorate in biochemistry from the University of Kansas.“For the last 30 years, I’ve focused on building genomics companies to better understand the fundamental basis of human disease and improve the quality of treatment decisions through genomic diagnosis. It is with great excitement that I now join the BridgeBio board to take the next step in bringing multiple therapies for genetic disorders to market,” said Dr. Scott. “Genetic disorders are much more common than previously thought, and BridgeBio has the unique opportunity to efficiently bring multiple life-saving products to the clinic at an accelerating pace. With my experience in building and scaling companies, I plan to focus on helping the BridgeBio team to scale the organization and build a world-class pharmaceutical company focused on solving genetic disease.”Andrew Lo, Ph.D.Dr. Lo brings his vast knowledge and understanding of economics and financial engineering to BridgeBio and will advise the company on how to continue accessing financing from a range of markets to broaden its work for patients and pursue more groundbreaking scientific innovation. As a famously innovative and iconoclastic thinker, he will also challenge the company to continue to innovate in areas as diverse as R&D process, clinical trial statistics, and talent management.Dr. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management, director of the MIT Laboratory for Financial Engineering, a principal investigator at the MIT Computer Science and Artificial Intelligence Laboratory, and an affiliated faculty member of the MIT Department of Electrical Engineering and Computer Science. His research spans several areas of financial economics, but his most recent focus is on developing new statistical tools for predicting clinical trial outcomes, incorporating patient preferences into the drug approval process and accelerating biomedical innovation through novel financing structures. His work formed the foundation for BridgeBio’s business model, and he is one of the company’s co-founders. Dr. Lo earned his bachelor’s degree in economics from Yale University and a master’s degree and doctorate in economics from Harvard University.“It’s remarkable to see the significant progress that BridgeBio has made in the five years since its founding to develop new medicines for genetically driven diseases,” said Dr. Lo. “I’m excited and honored to join the BridgeBio board and look forward to contributing in whatever ways I can to help them bring new therapies to patients who have no other alternatives.”About BridgeBio Pharma
BridgeBio is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. BridgeBio’s pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development. For more information, please visit bridgebio.com.
Contact:
Grace Rauh
BridgeBio Pharma, Inc.
Grace.rauh@bridgebio.com
(917) 232-5478
Source: BridgeBio Pharma, Inc.

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Global Penetration Testing Market 2020-2025 – Increased Adoption of Cloud-based Penetration Testing Presents Opportunities

GlobeNewswire

Published

on

Dublin, July 10, 2020 (GLOBE NEWSWIRE) — The “Penetration Testing Market by Component (Solutions & Services), Application Area (Network Infrastructure, Web Application, Mobile Application, Cloud, & Social Engineering), Deployment Mode, Organization Size, Vertical, and Region – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.This market study covers the penetration testing market size across segments. It aims at estimating the market size and the growth potential of this market across segments categorized into components, application areas, verticals, and regions. The study also includes an in-depth competitive analysis of the key market players, along with their company profiles, key observations related to product and business offerings, recent developments, and key market strategies.Significant rise in mobile-based business-critical applications require more secure endpoint protection is driving the overall growth of the penetration testing marketThe market growth is driven by various factors, such as the need to secure endpoint protection due to the significant rise in mobile-based business-critical applications and enterprises moving toward implementing security measures due to increased sophistication in cyberattacks.By application area, the mobile application penetration testing segment to grow at the highest CAGR during the forecast periodMobile application penetration testing is basically for mobile-based applications which is done by trying to break into various mobile applications through different vectors. The methodology is a security testing, which is used to analyze security from the inside of a mobile environment. The mobile application penetration testing methodology concentrates on file system, hardware, and network security.The test results can provide an organization with knowledge of the vulnerabilities in the mobile application, loopholes, and attack vectors before delivering an app to the user, thus offering insights on how to mitigate the potential risks of mobile applications and secure the user credentials associated with it. Mobile application users are becoming aware of the different threats and thus the deployment of mobile application penetration testing is rapidly increasing. Therefore, the mobile application penetration segment is expected to grow at the highest CAGR during the forecast period.By deployment mode, the cloud segment to grow at a higher rate during the forecast periodIn the cloud deployment mode, instead of implementing the software solution on the local hardware, businesses subscribe to the solution hosted on a third-party remotely located server. By opting for cloud-based solutions, organizations can avoid costs related to maintenance of infrastructure and technical staff.Cloud-based platforms are beneficial for organizations that have strict budgets for security investments. Small and Medium-sized Enterprises (SMEs) deploy their identity verification solutions on the cloud, as it saves them from investing their capital on security infrastructures. Hence, the cloud deployment segment is expected to grow at a higher CAGR.Asia-Pacific to register the highest growth rate during the forecast periodAsia-Pacific (APAC) has great scope for the growth of the penetration testing market. The penetration testing market in APAC is anticipated to grow significantly, due to increasing government investments in improving security posture, increased sophistication of cyberattacks, and the amalgamation of technologies, such as Artificial Intelligence (AI) and Machine Learning (ML) with penetration testing.The fast expansion of regional enterprises in APAC is another crucial variant contributing to the growth of the penetration testing market. In the process of determining and verifying the market size for several segments and subsegments gathered through secondary research, extensive primary interviews were conducted with key people.Key Topics Covered
1 IntroductionFor more information about this report visit https://www.researchandmarkets.com/r/fm043xResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Continue Reading

Artificial Intelligence

The Global Beauty Drinks Market is expected to grow from USD 1,943.82 Million in 2019 to USD 3,004.65 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.52%

GlobeNewswire

Published

on

New York, July 10, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Beauty Drinks Market Research Report by Ingredient, by Type, by Demography – Global Forecast to 2025 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p05913553/?utm_source=GNWClare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Continue Reading

Artificial Intelligence

Intrusion Detection and Prevention Market to grow at 9% CAGR to hit US $7 billion by 2025– Global Insights on Key Trends, Investments Analysis, Expansion Plans, Leading Players and Future Outlook: Adroit Market Research

GlobeNewswire

Published

on

Dallas,Texas, July 10, 2020 (GLOBE NEWSWIRE) — The “Intrusion Detection and Prevention Market by Component (Platform and Services), Type (Wireless-Based, Host-Based, Network-Based, and Network Behavior Analysis), Industry Vertical (BFSI, IT & Telecom, Healthcare, Retail, Manufacturing, and Others), and by Region, Global Forecast, 2018 to 2025” study provides an elaborative view of historic, present and forecasted market estimates.Request a pdf sample at https://www.adroitmarketresearch.com/contacts/request-sample/1542The global intrusion detection and prevention market size is anticipated to reach over USD 7 billion by 2025. It is expected that it will grow at a CAGR of over 9% during the forecast period 2018-2025. The intrusion detection and prevention is the procedure of examining the actions happening on the network and evaluating them for any future incidents or threats. Also, with the capability of automation and artificial intelligence, the intrusion detection, and prevention systems not only detect the prominent threats but they automatically take preventive measures against such threats. Hence, eliminates the need for checking every single security issue by the security administrator.The current and future intrusion detection and prevention market advances are defined to state the attractiveness of the market. Key impacting aspects focus on the intrusion detection and prevention market opportunities during the forecast period. Factors such as the rising number of cyber-attacks and data breaches are also the vital factor boosting the global intrusion detection and prevention market growth. Also, the growing data protection regulations and laws are other factors boosting the demand for intrusion detection and prevention solutions. However, However, the availability of free and open-source solutions are expected to impede market growth. Furthermore, the rising demand for cloud-based solutions and the growing BYOD trend in various organizations are some of the key factors expected to provide major growth opportunistic for the market in forthcoming years.Browse the full report with Table of Contents and List of Figures at https://www.adroitmarketresearch.com/industry-reports/intrusion-detection-and-prevention-marketThe report also highlights various aspects of the global intrusion detection and prevention industry by analyzing the market through value chain analysis. Besides, the Intrusion Detection and Prevention market report covers different qualitative aspects of the intrusion detection and prevention industry in market drivers, key industry opportunities, and restraints. Furthermore, the report proposes a comprehensive valuation of the market competitiveness along with company profiling of residents as well as global vendors.The intrusion detection and prevention market has solid competition among the early established and new players. Also, to capture a competitive advantage over the other industry players many industry players are aiming potential markets by forming collaboration and partnerships, agreements, mergers & acquisitions, acquiring new startups & other companies, and escalating their business presence.Direct purchase the report at https://www.adroitmarketresearch.com/researchreport/purchase/1542In terms of industry vertical, the market is segmented into BFSI, IT & telecom, healthcare, retail, manufacturing, and others. The IT and telecom industry dominated the overall IDP market in 2019 and it is expected to do so throughout the forecast period. The growth of this segment is mainly attributed to the increasing attacks on IT infrastructure. However, the BFSI industry is anticipated to gather the major market growth during the forecast period due to the increasing adoption of smart banking solutions.The Asia-Pacific region is projected to experience the highest growth throughout the forecast period. On the contrary, the North American region dominated the overall market in 2019 and it is expected to maintain its position throughout the forecast period 2018-2025. The dominance of this region is mainly attributed to the stringent regulations and increasing government initiatives to counter cyber-attacks.Are you looking for a DISCOUNT? If yes, then get in touch with us at https://www.adroitmarketresearch.com/contacts/discount/1542The major players of the global intrusion detection and prevention market are Cisco, IBM, Palo Alto Networks, McAfee, Trend Micro Incorporated, Fortinet, FireEye, AT&T Intellectual Property, Darktrace, and Huawei Technologies Co. Moreover, the other potential players in the intrusion detection and prevention market are WatchGuard Technologies, Vectra AI, Armor Defense, Hilstone Networks, and AlertLogic. The recognized companies are coming up with innovative and new Intrusion Detection and Prevention Types. For instance, in April 2019, Trend Micro, a cybersecurity solutions provider partnered with Luxoft Holding, a digital strategy firm. With this partnership both the companies are planning to introduce Intrusion Prevention Systems (IPS) and Intrusion Detection System (IDS) to detect and prevent cyber-attacks on connected cars.Major points from Table of Contents:
Chapter 1    Introduction
Chapter 2    Research Methodology
Chapter 3    Executive Summary
Chapter 4    Market Outlook
Chapter 5    Intrusion Detection and Prevention Market by Component
Chapter 6    Intrusion Detection and Prevention Market by Type
Chapter 7    Intrusion Detection and Prevention Market by Industry Vertical
Chapter 8    Intrusion Detection and Prevention Market by Region
Chapter 9    Competitive Landscape
Chapter 10    Company Profiles
Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html  About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us:
Ryan Johnson
Account Manager – Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1 972-362 -8199
Connect with us: Facebook | Twitter | LinkedIn

Continue Reading

Trending

Roboticulized is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Roboticulized digests / hand picks the latest news about the AI industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Roboticulized.com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania